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Abstract
Background: Identification of antigenic peptide epitopes is an essential prerequisite in T cell-based molecular
vaccine design. Computational (sequence-based and structure-based) methods are inexpensive and efficient
compared to experimental approaches in screening numerous peptides against their cognate MHC alleles. In
structure-based protocols, suited to alleles with limited epitope data, the first step is to identify high-binding
peptides using docking techniques, which need improvement in speed and efficiency to be useful in large-scale
screening studies. We present pDOCK: a new computational technique for rapid and accurate docking of flexible
peptides to MHC receptors and primarily apply it on a non-redundant dataset of 186 pMHC (MHC-I and MHC-II)
complexes with X-ray crystal structures.
Results: We have compared our docked structures with experimental crystallographic structures for the
immunologically relevant nonameric core of the bound peptide for MHC-I and MHC-II complexes. Primary testing
for re-docking of peptides into their respective MHC grooves generated 159 out of 186 peptides with Ca RMSD of
less than 1.00 Å, with a mean of 0.56 Å. Amongst the 25 peptides used for single and variant template docking,
the Ca RMSD values were below 1.00 Å for 23 peptides. Compared to our earlier docking methodology, pDOCK
shows upto 2.5 fold improvement in the accuracy and is ~60% faster. Results of validation against previously
published studies represent a seven-fold increase in pDOCK accuracy.
Conclusions: The limitations of our previous methodology have been addressed in the new docking protocol
making it a rapid and accurate method to evaluate pMHC binding. pDOCK is a generic method and although
benchmarks against experimental structures, it can be applied to alleles with no structural data using sequence
information. Our outcomes establish the efficacy of our procedure to predict highly accurate peptide structures
permitting conformational sampling of the peptide in MHC binding groove. Our results also support the
applicability of pDOCK for in silico identification of promiscuous peptide epitopes that are relevant to higher
proportions of human population with greater propensity to activate T cells making them key targets for the
design of vaccines and immunotherapies.
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Background
The molecular machinery by which an antigen presenting
cell (APC) presents T cell epitopes for recognition by T cell
receptors (TR) and subsequent activation of T cells fol-
lowed by the immune response cascade is fascinating. T
cell epitopes are short antigenic peptide sequences (p) that
are bound to and presented by the major histocompatibility
complexes (MHC) for recognition by the TR [1]. These epi-
topes are essential subunit peptides that are required in
order to stimulate cellular immune responses, especially the
adaptive immune responses. Peptide epitopes can be of
endogenous (processed within the cell) or exogenous (pro-
cessed outside the cell) origins, which are presented for sur-
veillance and recognition by the TR in an MHC allele and
supertype dependant manner. Broadly classified into two
types, MHC class I (MHC-I) complexes bind and present
endogenous peptides whereas MHC class II (MHC-II)
complexes prefer exogenous peptides. Typically, MHC-I
proteins are heterodimers, consisting of a heavy a chain (I-
ALPHA) of about 45 kDa, and a light chain, b2-microglo-
bulin (Β2M) of about 12 kDa [2,3]. The a chain consists of
a1 (G-ALPHA1), a2 (G-ALPHA2) and a3 (C-LIKE)
domains where G-ALPHA1 and G-ALPHA2 domains form
the peptide binding groove or ‘cleft’ [4]. MHC-II proteins
are also heterodimeric proteins consisting of an a chain (II-
APLHA; 34 kDa) and a b chain (II-BETA; 29 kDa) with
very similar overall quaternary structure to that of MHC-I
proteins [5-10]. However, their peptide binding groove is
formed by the a1 and b1 domains of the two chains.
Peptides presented by MHC-I are generally between 8-
11 amino acids in length. These peptides are ‘chopped’
within the cytosol of the cell by cytosolic proteases and
are transported to the MHC binding groove within the
endoplasmic reticulum by the transporters associated
with antigen processing (TAP) proteins in an ATP
dependant manner. Following which, the peptides bind
to the MHC to form the peptide-MHC (pMHC) com-
plex which is then transported to the APC cell surface
and presented for recognition by the TR of CD8+ cyto-
toxic T cells (CTLs). Similarly, the peptides presented
by MHC-II are usually 12-25 amino acids in length and
are endocytosed into the cell by the lysosomes where
they bind the MHC-II proteins by displacing the original
MHC-II ligand known as the ‘CLIP’ peptide to form the
pMHC complex. And again, they are transported to the
APC cell surface for recognition by the TR of the CD4+
T helper cells. Identification of true T cell epitopes from
the repertoires of immunologically significant antigenic
peptide sequences is a vital prerequisite in the process
of conventional molecular vaccine design for prevention
and treatment of infectious, autoimmune, allergic and
graft vs. host diseases. The key step in TR-mediated
immune response is thus the binding and presentation
of antigenic endogenous or exogenous peptide epitopes,
which can be reasonably well predicted using sequence-
based methods for alleles with large datasets of known
binding peptides, as reviewed earlier [11,12].
Experimental identification of T cell epitopes is a
tedious, time consuming and expensive process owing
to the large number and diversity of both MHC alleles
and the antigenic peptides. Not to mention, is the extre-
mely low chance of immunogenicity (1 in 2000 peptides)
even amongst the peptides that bind strongly to the
MHC (50%) [13]. Recently developed computational
methods have proven to be vastly time and cost efficient
in screening the vast oceans of peptides and MHC
repertoires [14]. Current computational methods can be
broadly classified into: 1. Sequence-based approaches
which use sequence motifs [15], matrix models [16,17],
Artificial Neural Network [18-20], Hidden Markov
Model [21] and Support Vector Machine [22-24] for
large-scale screening of potential T cell epitopes from
protein sequence databanks and 2. Structure-based
approaches such as protein threading [25,26], homology
modeling [27,28], rigid docking [29] and flexible docking
[2,3] which utilize three-dimensional data for detailed
structural analysis of interactions between the MHC and
bound segmental antigenic peptides. The former are
more suitable for large-scale screening of potential T
cell epitopes, while the latter work better for detailed
analysis of short immunogenic regions of antigens [2].
Although sequence-based methods are well established,
a major limitation of such techniques is the heavy reli-
ance on the availability of large comprehensive training
sets of peptides. Thus, these approaches are not appro-
priate for accurate prediction of peptides in circum-
stances where the data available is insufficient.
Therefore, the coverage of sequence-based techniques is
limited to subsets of binding peptides that belong to the
most numerous groups and cannot generate reliable
data for peptides that are least represented in the data-
set [2], leaving structural immunoinformatics as the only
option for such peptides [3,5-7].
Antigenic peptides that bind strongly to MHC alleles
are known to elicit T cell responses [1-3,5-7,11]. Hence,
their identification is a vital first step in the process of
structure-based immune epitope prediction. The usual
approach adopted to address this important issue is to
utilize a powerful concept, based on the principle of
structure-based drug design called “docking”, where
peptides are computationally placed in MHC grooves in
the best orientation, reflecting steric and electrostatic
complimentarity, using structure-based docking techni-
ques. The accuracy with which the peptides are docked
is measured in terms of Root Mean Square Deviation
(RMSD) values obtained by comparing the docked
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conformations of the peptides to their original bound
conformations in the respective X-ray crystal structures.
With the development of new structural modeling and
docking techniques and an increase in the number of
protein structures deposited in the Protein Data Bank
(PDB) [30] and the IMGT/3Dstructure-DB [31,32],
structure-based approaches are being more commonly
used to predict potential T cell epitopes [33], often pro-
ducing modeled structures accurate to within 2.00Å
RMSD from the experimental crystal structure, provid-
ing a wealth of information for structural analysis and
the development of prediction methods.
The development of an accurate protocol for flexible
docking has helped us to successfully carry out quantita-
tive predictions for both MHC-I and MHC-II alleles
even with limited binding peptide data [3,5-7]. Our ear-
lier docking protocol consisted of three steps (extended
to four for pMHC-II complexes for incorporating the
flanking residues on either side of the nonameric core,
which is the 9-mer anchored to the MHC molecule): (1)
rigid docking of the peptide nonamer termini into the
MHC binding groove; (2) loop closure of central resi-
dues by satisfaction of spatial constraints; (3) followed
by iterative ab initio refinements of ligand backbone
and; (4) extension of flanking peptide residues by satis-
faction of spatial constraints [2,3] (only for MHC-II
related peptides). While accurate, this approach has
multiple steps, resulting in suboptimal computational
speeds. Therefore, the efficiency of this protocol for
peptide docking to MHC needs to be improved for
large-scale screening of T cell epitopes. A grid-based
docking methodology has earlier been reported [34] to
be highly accurate in pMHC docking over a limited
MHC-I data. Hence, we have developed a grid-based
peptide docking method (pDOCK) and have extensively
tested it on both MHC-I and MHC-II peptides. The
motivation behind the development of a faster and more
accurate peptide docking methodology was to eventually
improve the qualitative and quantitative efficacy of
structure-based T cell epitope prediction.
In this study, we present pDOCK: a new computa-
tional technique for rapid and accurate docking of flex-
ible peptides to the MHC receptors and primarily apply
it to re-dock a non-redundant dataset of 186 (149
MHC-I and 37 MHC-II related) peptides, from MPID-
T2 (http://biolinfo.org/mpid-t2) database for which X-
ray crystal structures are available in the PDB and the
IMGT/3Dstructure-DB, back into their respective MHC
grooves. pDOCK comprises of two input preparatory
steps followed by a single consolidated docking and
refinement step as depicted in Figure 1. The pDOCK
protocol involves: Preparatory step 1: receptor modeling
and positioning; Preparatory step 2: determining the
docking grid by defining the grid dimensions (length x
breadth x height) for ligand placement and grid map
generation within the vicinity of the receptor’s binding
site and; Final docking and refinement step: ligand posi-
tioning within the grid, flexible docking of the peptide
into the peptide binding groove and refinement of all
ligand and binding site residues using the Internal Coor-
dinate Mechanics (ICM) global optimization, docking
algorithm [35] and a biased Monte Carlo procedure (see
Methods section for more details). Our preliminary ana-
lysis of all pMHC complexes from the MPID-T2 data-
base has provided us with standardized dimensions for
the 3-D docking grids for both class I and class II
pMHC structures. These standardized values were used
to set the dimensions of the docking grids in all our
experiments. Unlike the previously reported grid-based
docking method [34], homology model building for
MHC receptors has not been used in the development
of pDOCK, instead using only experimentally deter-
mined X-ray crystallographic structures. The pDOCK
method, however, is generic and is applicable to high
quality homology models of alleles when experimental
structures are not available. Here, the receptor modeling
sub-step mentioned in the preparatory step 1 (Figure 1)
can be used in the absence of structural data for the
MHC proteins. Thus, the direct use of X-ray crystal
structures in our docking simulations ensures accurate
results.
The first experiment that we conducted was to ensure
that an extended peptide bound to its cognate MHC
receptor preferentially selecting the same nonameric
core peptides as in the crystal structure and then to
evaluate the accuracy of the docked peptide. Hence, we
performed re-docking of 186 peptides back to their cog-
nate MHC receptors to check for conformational accu-
racy of the predicted binding registers and their Ca
RMSD against their respective crystal structures. We
have then benchmarked pDOCK with our earlier dock-
ing protocol [2,3] for a dataset of 50 selected (35 MHC-
I and 15 MHC-II) pMHC complexes to verify the speed
and accuracy of pDOCK against our earlier method.
This was followed by validation and accuracy checks for
pDOCK against available flexible peptide docking results
obtained from the literature for a dataset of 15 peptides.
In the process of selecting immunogenic peptides for
vaccine design, the two main aspects are to determine:
(1) multiple peptides that bind to the same allele or
MHC molecule and; (2) promiscuous or same peptides
that bind multiple alleles. Therefore, as a secondary
experiment, we have pursued to test the efficacy and
robustness of our docking protocol in modeling the
bound conformations of novel peptides to specific MHC
alleles by carrying out docking of multiple peptides to a
single MHC template structure (same MHC allele), sui-
table for immune epitope prediction from an antigenic
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protein, using a moving window of 9-mers along the
entire sequence [3,5-7]. Our third experiment was to
dock a single peptide from particular PDB structures
onto multiple MHC templates (multiple alleles) from
other crystal structures, suitable for determining promis-
cuous peptides capable of binding to a set of related
alleles and therefore, important for vaccine design.
The Ca RMSD values have been calculated only for
the nonameric core of the peptide (for both MHC-I and
MHC-II related peptides) which is a contiguous immu-
nogenic segment that forms the “binding register”
within the MHC peptide binding cleft, as reported ear-
lier by our group [3]. For the peptides with nine and
less number of amino acid residues the entire peptide
Figure 1 Flowchart of the pDOCK protocol used in this work. The two preparatory steps followed by a single consolidated docking and
refinement step, are shown here.
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was used for Ca RMSD calculation. pDOCK accurately
detected all 186 binding registers, i.e., the nonameric
cores of the peptides are identical to their respective
crystal structures. pDOCK generated 85.5% of all the
peptides with Ca RMSD of less than 1.00 Å compared
to their respective X-ray crystal structures. Our bench-
marking results imply up to 2.5 fold improvement in the
accuracy of the new peptide docking methodology. The
validation results represent a sevenfold improvement in
the accuracy of our technique compared to that of the
existing methodologies in flexible docking and modeling
of peptides into MHC grooves. Amongst the 21 peptides
docked in the second experiment, the Ca RMSD values
for docked peptides compared to their respective crystal
structures were below 1.00 Å for 20 peptides (details in
Results and discussion section). The third experiment
accounted for all 4 peptides docked with less than 1.00
Å Ca RMSD compared to the same peptides from the
corresponding template crystal structures (details in
Results and discussion section). Overall, pDOCK is up
to 60% faster than our earlier protocol and hence pro-
vides a rapid and accurate docking method to evaluate
pMHC binding for large scale immune-epitope
prediction.
Results and discussion
The fact that our earlier method was comparatively
slower and that it involved rigid-docking of the peptide
termini, acted as the platform for us to ‘revisit’ our
pMHC docking methodology. Based on these require-
ments, we have developed a single step pMHC docking
protocol (details in Methods section) as shown in Figure
1, which allows flexibility over the entire length of the
peptide antigen and can be used as a generic method to
obtain the conformations of bound peptide ligands to
MHC binding grooves of both class I and class II MHC
proteins. A systematic evaluation of pDOCK is per-
formed as three separate tests: (1) exhaustive re-docking
of all non-redundant peptides to their respective MHC
grooves as a test case, benchmarking and validation; we
then address two very significant practical problems
faced by immunologists during the process of allele-spe-
cific peptide vaccine design: (2) the docking of multiple
peptides that bind to same MHC allele, for immuno-
genic epitope scanning of antigenic sequences and; (3)
docking of promiscuous peptides or same peptides bind-
ing to multiple MHC alleles for vaccine design, based on
groups of disease-implicated alleles. A correctly docked
structure is defined as the peptide with at most 2.50 Å
Ca RMSD from the respective experimental X-ray crys-
tal structure [2]. pDOCK has also been benchmarked
against our previous docking protocol and validated on
published peptide modeling and docking results from
the literature. Bordner and Abagyan [34] suggested that
while grid-based docking could be applied for pMHC-II,
it was a more difficult problem. pDOCK has been suc-
cessfully applied for MHC-II peptide docking as well
with excellent results.
Experiment 1
Re-docking bound peptides to their cognate MHC grooves
pDOCK has been applied on a non-redundant dataset of
186 (149 MHC-I and 37 MHC-II) pMHC complexes
from the MPID-T2 database (details in Methods section,
data and docking results in Additional File 1 – Table
S1). Initially, the peptides were extracted from the
experimental pMHC complexes, randomized and set to
extended conformations. This was followed by optimiza-
tion of the peptide ligands and re-docking of the sepa-
rated peptides back to their respective MHC grooves.
As depicted in Figure 2, our technique generated 159
out of 186 peptides with Ca RMSD values less than
1.00 Å: 124 out of 149 peptides (83%) and 35 out of 37
peptides (~95%) for class I and class II MHC proteins,
Figure 2 Distribution of Ca RMSD of the docked peptides and
their respective crystal structures across the non-redundant
MPID-T2 dataset for peptides for a. MHC-I complexes and b.
MHC-II complexes. Most of the peptides from both MHC-I (124/
149; 83%) and MHC-II (35/37; ~95%) datasets have their Ca RMSD
values below 1.00 Å, highlighting the accuracy of our docking
protocol. The number of peptides in each Ca RMSD range is given
in parentheses.
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respectively. ~15% (22/149) and ~1% (2/149) of the pep-
tides have their Ca RMSD values within the ranges
1.01-2.00 Å and 2.01-2.50 Å, respectively amongst the
MHC-I peptides docked (Figure 2a). Similarly, ~5% of
the peptides have their Ca RMSD values within a range
of 1.01-1.30 Å amongst the MHC-II related peptides
that were docked using pDOCK (Figure 2b). On an
average, pDOCK resulted in a Ca RMSD value of about
0.56 Å for re-docking of peptides into their respective
MHC grooves over the entire dataset of 186 pMHC
complexes.
Our best results are shown in Figure 3, with structural
comparison between the lowest energy docked confor-
mation and the native conformation of the bound pep-
tides for MHC-I (PDB code 1s7q) and MHC-II (PDB
code 1d5x) structures. These docked conformations of
peptide structures have the best Ca RMSD values of
0.09 Å and 0.11 Å respectively, obtained over the entire
dataset. The MHC-II peptide in Figure 3b has 5 out of
6 amino acid residues replaced by amino acid analogues
(chemical mimics) in the crystal structure. Nonetheless,
it has the best Ca RMSD value among all the MHC-II
related peptides used in this study, supporting pDOCK’s
applicability to peptide or peptide analogues (containing
amino acid mimics in structure-based drug design).
pDOCK also generated the least energy docked orienta-
tions for all the peptides with accurate determination of
their respective binding registers, i.e. having the exact
nonameric core in the binding grooves, with respect to
their native bound conformations in the X-ray crystal
structures. All peptides except one from the class I
pMHC crystal structure (PDB code 2gtw; Ca RMSD of
3.08 Å) were within the acceptable 2.50 Å Ca RMSD
from their respective native conformations (Figure 2a).
Also, none of the MHC-II related peptides showed any
deviation from the acceptable 2.50 Å Ca RMSD thresh-
old (Figure 2b).
We carefully examined the re-docked conformation of
the peptide LAGIGILTV in the MHC groove of the
complex 2gtw, with the X-ray structure. In 2gtw, peptide
residues 1 to 5 interact with a formic acid molecule,
which was not explicitly introduced into the docking
simulation. When the formic acid molecule was
included in the docking simulation, the predicted orien-
tation of the peptide using pDOCK is energetically more
favourable for pMHC complex formation than the pre-
dicted conformation when the formic acid molecule is
omitted. The improvement in accuracy by the inclusion
of the formic acid molecule is ~13 folds. This is por-
trayed in Figure 4 which clearly indicates that the pep-
tide residues Leu 1, Ala 2, Gly 3, Ile 4 and Gly 5 that
are not correctly predicted in the absence of the formic
acid molecule (Figure 4a), are accurately docked when
the formic acid molecule is introduced into the docking
simulation (Figure 4b), resulting in an improvement in
the Ca RMSD value from 3.08 Å to 0.24 Å.
Although water molecules and other common biologi-
cal ions such as phosphate and chloride may mediate
pMHC interactions in some cases, they were omitted
from our experiments because the significance and con-
tributions of these molecules towards pMHC binding
vary immensely between different peptides and specific
alleles over a large dataset like the one used in this
study (186 complexes). Our previous protocol achieves a
Ca RMSD of 1.53 Å for the bound structure of the pep-
tide from pMHC complex 1jf1, due to the presence of a
water molecule positioned around the peptide residues 5
to 7 in the crystal structure leading to erroneous predic-
tion of the loop formed, which resulted in incorrect
positioning of interacting residues [2]. However,
pDOCK successfully overcomes this restriction to accu-
rately predict the least energy bound conformation of
this peptide with a Ca RMSD value of 0.30 Å. The
enhancement in accuracy of docking is a direct
Figure 3 Comparison of the lowest energy predicted and the experimental structures of the cognate peptides with the least RMSD
values across the pDOCK test set. a. KAVYNFATM peptide in the MHC-I complex 1s7q (PDB code). b. XXRXXX peptide in the MHC-II
complex 1d5x (PDB code). The peptides are shown in stick representation of all heavy atoms. The Ca RMSD values between the lowest energy
docked conformation (green) and the native conformation of the bound peptides (blue) for the MHC-I structure 1s7q (PDB code) and the MHC-II
structure 1d5x (PDB code) are 0.09 Å and 0.11 Å, respectively. X: Amino acid analogues (chemical mimics).
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consequence of the improved sampling of available con-
formational space in pDOCK. This preliminary experi-
ment is a critical first step as it establishes the validity
of our approach and helps us test the ability of our
technique to accurately dock cognate peptides into their
respective MHC receptors, using the proposed single-
step docking procedure.
Benchmarking with our previous methodology
In order to ascertain the improvement in speed and accu-
racy of pDOCK compared to the old technique, we have
benchmarked our peptide docking methodology with our
earlier pMHC docking protocol [2,3] over a subset of 50
pMHC complexes (35 MHC-I and 15 MHC-II) from the
complete non-redundant dataset (listed in Additional File
1 – Table S1) and the results are presented in Table 1.
pDOCK results are consistently better than our earlier
docking methodology in terms of accuracy (Ca RMSD)
of the modelled or docked peptide compared to their X-
ray crystal structures after docking back into their
respective MHC grooves. The new protocol also gener-
ates the least energy docked conformations for all 50
peptides with Ca RMSD values less than 1.00 Å, com-
pared to eight peptides, docked using the earlier method,
having Ca RMSD values above 1.00 Å (graphically shown
in Additional File 2 – Figure S1). The new procedure
outmatches the old protocol particularly well for com-
plexes 1s9y, 1hhh, 1jf1, 1e27, 1jpf, 1qo3, 1wbz and 1g7p
(Table 1) amongst the MHC-I structures and for struc-
tures 1uvq and 1aqd (Table 1) amongst the MHC-II
structures (highlighted in yellow in Additional File 2 –
Figure S1).
These results suggest that some of the conformational
limitations of our previous methodology, such as the
presence of water molecules in and around the peptide
and within the peptide binding groove in the original
PDB structure, have been addressed in our new docking
protocol making it highly accurate. Besides an improve-
ment in the accuracy, pDOCK is also able to accurately
model docked conformations for some peptides espe-
cially for MHC-II related peptides with more than 9
amino acid residues, thereby improving the coverage
over the entire length of the peptides. Peptides from the
pMHC complexes 1uvq and 2iam were among the high-
est coverage (20 and 15 residues respectively) obtained
in this experiment with Ca RMSD values 0.42 Å and
0.46 Å respectively over the length of the entire peptide
(results not shown). The reliability for the accurate pre-
diction of flanking residues (especially for MHC-II pep-
tides) depends upon their interactions with the MHC
residues outside the peptide binding groove and there-
fore, have not been included in the calculation of Ca
RMSD values reported.
In terms of the computational time to complete a sin-
gle docking experiment, pDOCK is up to 60% faster (on
an average) than the earlier method as summarized in
Table 2. The average time taken by pDOCK is approxi-
mately 10 min. (the preparatory receptor positioning
step of ~3 sec. {0.50%}, determining the docking grid
taking ~42.6 sec. {7.10%} and the single docking and
refinement step of ~9.24 min. {92.4%}), compared to
23.50 to 24.50 min (Step 1 taking ~5 min., Step 2 of
~30 sec., Step 3 taking ~18 min. and Step 4, which was
only applicable to MHC-II related peptides, of ~1 min.)
using the old protocol on a 2 CPU 3.20 GHz 3 GB
RAM workstation. The average time taken for each of
the steps using either of the methodologies is calculated
over the entire non-redundant dataset of 186 pMHC
complexes catalogued in additional file 1 – table S1.
The mean Ca RMSD value for the least energy docked
conformations of peptides, from the dataset of 50 pep-
tides used for benchmarking, was 0.27 Å using pDOCK
compared to 0.65 Å for the old procedure. This denotes
almost two and a half fold improvement in the accuracy
of our novel docking strategy over a larger dataset (50
peptides) than that used previously (40 peptides) [2].
Figure 4 Structural comparison of the lowest energy docked
conformations and the experimental structures of the bound
peptide for the pMHC structure 2gtw when the formic acid
molecule was a. omitted and b. included in the docking
simulation. The peptides are shown in stick representation of all
heavy atoms. The Ca RMSD values between the lowest energy
predicted (green) and the native conformation of the cognate
peptide (blue) for the structure 2gtw when the formic acid
molecule was omitted and included in the docking protocol were
3.08 Å and 0.24 Å respectively. The peptide residues of its native
conformation that were not accurately docked in the absence of
the formic acid molecule are labeled in black in (a). The formic acid
molecule is depicted in red in (b).
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Table 1 Benchmarking pDOCK with our earlier methodology
S. No. Allele PDB Peptide Length Peptide Sequence Ca RMSD (Å)
Previous method pDOCK
MHC-I
1 HLA-A*1101 1qvo 10 QVPLRPMTYK 0.53 0.24
2 HLA-A*0201 1qr1 9 IISAVVGIL 0.46 0.29
3 HLA-A*0201 1akj 9 ILKEPVHGV 0.87 0.39
4 HLA-A*0201 1i1y 9 YLKEPVHGV 0.70 0.66
5 HLA-A*0201 1i7r 9 FAPGFFPYL 0.59 0.47
6 HLA-A*0201 1i7u 9 ALWGFVPVL 0.32 0.29
7 HLA-A*0201 1oga 9 GILGFVFTL 0.32 0.16
8 HLA-A*0201 1qsf 9 LLFGYPVAV 0.54 0.34
9 HLA-A*0201 1lp9 9 ALWGFFPVL 0.58 0.26
10 HLA-A*0201 1s9y 9 SLLMWITQS 1.09 0.39
11 HLA-A*0201 1hhh 10 FLPSDFFPSV 1.10 0.49
12 HLA-A*0201 1jf1 10 ELAGIGILTV 1.53 0.30
13 HLA-B*0801 1agc 8 GGKKKYQL 0.28 0.23
14 HLA-B*0801 1mi5 9 FLRGRAYGL 0.42 0.37
15 HLA-B*2705 1ogt 9 RRKWRRWHL 0.51 0.18
16 HLA-B*2705 2a83 9 RRRWHRWRL 0.55 0.18
17 HLA-B*3501 2cik 9 KPIVVLHGY 0.74 0.26
18 HLA-B*3508 3bwa 8 FPTKDVAL 0.56 0.26
19 HLA-B*5101 1e27 9 LPPVVAKEI 1.27 0.18
20 HLA-B*5301 1a1m 9 TPYDINQML 0.59 0.28
21 HLA-Cw*0401 1im9 9 QYDDAVYKL 0.49 0.34
22 HLA-G*0101 2dyp 9 RIIPRHLQL 0.43 0.16
23 H2-Db 1fg2 9 KAVYNFATC 0.25 0.19
24 H2-Db 3buy 9 LSLRNPILV 0.63 0.23
25 H2-Db 1yn7 10 SSLENFAAYV 0.62 0.14
26 H2-Db 1jpf 11 SGVENPGGYCL 1.14 0.36
27 H2-Dd 1qo3 10 RGPGRAFVTI 1.49 0.17
28 H2-Kb 1t0m 8 SSIEFARL 0.66 0.21
29 H2-Kb 1vac 8 SIINFEKL 0.32 0.22
30 H2-Kb 1wbz 9 SSYRRPVGI 0.89 0.19
31 H2-Kb 1s7q 9 KAVYNFATM 0.20 0.09
32 H2-Kb 1g7p 9 SRDHSRTPM 0.97 0.17
33 H2-Kd 1vgk 9 SYVNTNMGL 0.86 0.25
34 H2-Kk 1zt1 8 FEANGNLI 0.57 0.45
35 H2-Ld 2e7l 9 QLSPFPFDL 0.37 0.35
MHC-II
36 HLA-DQB1*0602 1uvq 20 MNLPSTKVSWAAVGGGGSLV 1.09 0.23
37 HLA-DRB1*0301 1a6a 15 PVSKMRMATPLLMQA 0.38 0.30
38 HLA-DRB1*0101 1aqd 14 GSDWRFLRGYHQYA 1.08 0.28
39 HLA-DRB1*0101 1fyt 13 PKYVKQNTLKLAT 0.68 0.23
40 HLA-DRB1*0101 2iam 15 GELIGILNAAKVPAD 0.56 0.24
41 HLA-DRB1*0401 1d5x 6 XXRXXX 0.23 0.11
42 HLA-DRB1*0401 1d5z 7 XXRAXSX 0.33 0.22
43 HLA-DRB1*0401 1d6e 8 XXRXMASX 0.32 0.14
44 HLA-DRB1*0401 1j8h 13 PKYVKQNTLKLAT 0.59 0.20
45 HLA-DRB3*0101 2q6w 11 AWRSDEALPLG 0.54 0.30
46 HLA-DRB5*0101 1fv1 20 NPVVHFFKNIVTPRTPPPSQ 0.88 0.59
47 I-Ad 1iao 14 RGISQAVHAAHAEI 0.81 0.27
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Validation against previously published studies
Keeping in mind the essence of improving the accuracy
and robustness of the proposed strategy, we have vali-
dated pDOCK with seven studies involving MHC-I pep-
tide docking/modeling and one study involving MHC-II
peptide docking, covering 15 pMHC structures and com-
pared the results by re-running our earlier method. The
results of our validation experiments are compiled into
Table 3. Peptides 1, 2, 3, 4 and 15 (Table 3) are new in
this study and are collated from recent publications
[34,36,37], whereas the remaining 10 were from the vali-
dation studies reported for our earlier methodology [2].
To the best of our knowledge, these results represent a
sevenfold increase in the accuracy of pDOCK compared
to available flexible docking techniques in the remodeling
of pMHC complexes. Interestingly, the validation criteria
for almost all of the previously published studies
[34,36-40] involved either docking or remodeling of pep-
tides back into their original crystal structure. Although
the Ca RMSD values (0.29 Å and 0.30 Å, respectively)
for peptides 2 and 3 (Table 3) were slightly higher, they
are still comparable with the Ca RMSD values reported
earlier (0.23 Å and 0.22 Å, respectively) [34]. Peptide 1
(Table 3) however, was generated with a better Ca
RMSD (0.31 Å) compared to the Ca RMSD (0.76 Å)
reported in the same earlier grid-based docking study
[34]. The enhancement in the accuracy for peptide 1
could be a direct implication of more conformational
sampling space in a flexible environment resulting from a
relatively larger docking grid (35.36 Å x 35.52 Å x 35.79
Å) for MHC-I peptides and a lower temperature (300 K)
used in pDOCK compared to the grid dimensions (34 Å
x 34 Å x 25 Å) and temperature (700 K) used in the pre-
vious grid-based docking study [34]. Thus, pDOCK is not
only comparable to but also surpasses the available tech-
niques in flexible docking and remodeling of peptides
with regards to the accuracy (Ca RMSD) with which it
predicts the bound structure of a peptide to its respective
MHC groove. By and large, our results illustrate the
advantages of using grid-based flexible docking over con-
ventional docking protocols.
Figure 5 provides a pictorial representation of an exam-
ple of the above discussed accuracy. This structural com-
parison between the least energy docked conformation
generated using pDOCK and that of the native conforma-
tion of the cognate peptide in the complex 1duz portrays
not only the highly accurate predicted conformation of the
peptide, Ca RMSD of 0.33 Å compared to that of 3.01 Å
reported earlier [37], but also highlights the fact that the
peptide’s N-terminal residues (Leu 1, Leu 2 and Phe 3)
were better modeled and structurally well aligned to that
of its native conformation when compared to the lowest
energy docked conformation reported earlier [37]. Nota-
bly, the least energy docked conformations generated for a
common murine MHC (H2-Kb) related Sendai virus
nucleocapsid peptide FAPGNYPAL and a very familiar
human HLA (A*0201) related Influenza A virus matrix
peptide GILGFVFTL have significantly lower Ca RMSD
values of 0.25 Å and 0.16 Å respectively (Table 3) than
those reported in earlier studies (2.70 Å and 0.46 Å, 1.60
Å, 1.40 Å respectively) [38,40-42] and those obtained
using our previous protocol (0.40 Å and 0.32 Å). These
observations establish the efficacy of pDOCK to dock
highly accurate multi-species related peptide structures
permitting conformational sampling of the peptide in the
binding groove during flexible docking.
Experiment 2
Docking of multiple peptides onto a single template
We applied pDOCK to a subset of 25 non-redundant
pMHC complexes (obtained from the pDOCK test set
of 186 pMHC complexes), with either a common allele
or a common peptide core. The dataset of 18 MHC-I
and seven MHC-II complexes comprises 21 (15 MHC-I
and six MHC-II related) novel peptides which were
known to bind to a single template (same allele) and
four (three MHC-I and one MHC-II related) promiscu-
ous peptides that were known to bind variant templates
Table 2 Comparison of computational time of pDOCK
with our earlier docking method
Previous method pDOCK
Step 1: ~ 5 min
Step 2: ~ 30 s Preparatory Step 1: ~ 3*s
Step 3: ~ 18 min Preparatory Step 2: ~ 42.6 s
Step 4#: ~ 1 min Single docking and refinement
step: ~ 9.24 min
Total: ~ 23.50 – 24.50 min Total: ~ 10 min
Both methodologies were applied using a 2 CPU 3.20 GHz 3 GB RAM
workstation. *Only for X-ray crystal structures of MHC proteins. The time taken
for this step would increase if homology modeling needs to be carried out.
#Applicable only to MHC-II related peptides.
Table 1 Benchmarking pDOCK with our earlier methodology (Continued)
48 I-Ak 1iak 13 STDYGILQINSRW 0.42 0.23
49 I-Au 2pxy 11 RGGASQYRPSQ 0.78 0.28
50 I-Ek 1r5v 13 ADLIAYPKAATKF 0.82 0.28
Ca RMSD values are calculated only for the nonamer binding cores (shown in bold) for peptides with more than 9 residues in the X-ray crystal structures. X:
Amino acid analogues (chemical mimics). A graphical representation of the results is available in Additional File 2 – Figure S1.
Khan and Ranganathan Immunome Research 2010, 6(Suppl 1):S2
http://www.immunome-research.com/content/6/S1/S2
Page 9 of 16
(multiple alleles). Due to lack of sufficient promiscuous
peptides available in the PDB, only four peptides are
currently tested. The results obtained from the docking
of peptides onto single templates are tabulated in Table
4. 20 out of 21 peptides were docked onto a single tem-
plate with Ca RMSD values less than 1.00 Å compared
to their respective experimental structures. Amongst the
results from single template docking experiments, the
most accurate docked conformation of the least energy
peptide, with a Ca RMSD of 0.06 Å compared to its
relevant PDB peptide structure (Table 4), was achieved
for the peptide from the structure 1kbg docked onto the
MHC from the structure 1nam having the same murine
MHC allele (H2-Kb) as the complex 1kbg.
Experiment 3
Docking of same peptides onto variant templates
Results from variant template docking experiments are
listed in Table 5. It is worth noting that the Ca RMSD
values for the peptides docked onto variant templates
were calculated in comparison to the same peptides pre-
sent in the respective template structures. This was
done due to the fact that although the peptides may be
similar, the environments encountered by the same pep-
tides are different in the binding grooves of different
MHC alleles. All four promiscuous peptides were
docked onto variant templates with Ca RMSD values
below 1.00 Å (Table 5). This observation suggests the
robustness of pDOCK in docking promiscuous peptides
onto multiple MHC alleles and its adaptability in order-
ing the binding registers or conformations of the pep-
tides according to the changed environments, due to
changes in the amino acid sequences, of the MHC
Figure 5 Structural comparison between the native
conformation and the lowest energy docked conformation of the
cognate peptide in MHC-I complex 1duz. The peptide is shown in
stick representation wherein the native conformation is in pink and the
docked conformation is in blue. The MHC peptide binding ‘groove’ is
shown as ribbons. The Ca RMSD between the native and the lowest
energy docked conformation of the bound peptide from our work is
0.33 Å which is up to three and a half times better than an earlier
reported Ca RMSD of 3.01 Å [37]. The peptide residues of our lowest
energy docked conformation that were better modeled and aligned to
that of its native conformation when compared to the lowest energy
docked conformation reported earlier [37] are labeled in black. This
structure is not listed in Additional File 1 - Table S1 since it was a
redundant structure in MPID-T2.
Table 3 Comparison of pDOCK with published MHC–peptide modeling and flexible docking methods
S.No Technique Peptide Sequence MHC class PDB RMSD (Å)
Published Previousmethod pDOCK
1 Grid-based Flexible docking [34] RGYVYQGL I 1kpu# 0.76 0.59 0.31
2 Grid-based Flexible docking [34] ALWGFVPVL I 1i7u 0.23 0.32 0.29
3 Grid-based Flexible docking [34] ELAGIGILTV I 1jf1 0.22 1.53 0.30
4 Monte Carlo annealing [37] LLFGYPVYV I 1duz# 3.01 0.33 0.33
5 Simulated annealing [38] FLPSDFFPSV I 1hhh 1.59 1.10 0.48
6 Simulated annealing [38] GILGFVFTL I 1hhi# 0.46 0.32 0.16
7 Simulated annealing [38] ILKEPVHGV I 1hhj# 0.87 0.87 0.55
8 Simulated annealing [38] LLFGYPVYV I 1hhk# 0.78 0.33 0.33
9 Combinatorial buildup algorithm [39] RGYVYQGL I 2vaa# 0.56 0.32 0.22
10 Combinatorial buildup algorithm [40] LLFGYPVYV I 1hhk# 1.40 0.33 0.33
11 Combinatorial buildup algorithm [40] ILKEPVHGV I 1hhj# 1.30 0.87 0.55
12 Combinatorial buildup algorithm [40] GILGFVFTL I 1hhi# 1.60 0.32 0.16
13 Multiple copy algorithm [41] FAPGNYPAL I 2vab# 2.70 0.40 0.25
14 Multiple copy algorithm [42] GILGFVFTL I 1hhi# 1.40 0.32 0.16
15 GOLD/GLIDE Flexible docking [36] XXRXMASX II 1d6e 1.24/3.06 0.32 0.14
X: Amino acid analogues (chemical mimics). #These structures are not listed in Additional File 1 - Table S1 due to redundancy in MPID-T2.
Khan and Ranganathan Immunome Research 2010, 6(Suppl 1):S2
http://www.immunome-research.com/content/6/S1/S2
Page 10 of 16
grooves in different MHC alleles. Out of the 4 promis-
cuous peptides, the peptide FAPGNYPAL from the
pMHC structure 2vaa having the murine MHC allele
H2-Kb, when docked onto the MHC from the structure
1ce6 with the murine MHC allele H2-Db, was generated
with the best Ca RMSD of 0.21 Å (Table 5) compared
to the same peptide from 1ce6. The highest Ca RMSD
value (0.79 Å) obtained using pDOCK during this
experiment was when the peptide from the structure
1zsd was docked onto the MHC from the structure
2ak4 (Table 5). This value is still well within the accep-
table value of 2.50 Å.
In all, only one peptide generated using pDOCK from
the single template docking experiments has the Ca
RMSD value above 1.00 Å (Table 4) compared to 5 pep-
tides (three from single template docking and two from
variant template docking) with Ca RMSD values above
1.00 Å using our previous methodology (Table 4 and
Table 5). It is thus clear that pDOCK accurately predicts
the structure of cognate peptides in both single and var-
iant template docking cases. These evaluation steps are
also vital to establish the efficiency with which our new
method can dock and subsequently predict novel pep-
tides onto given MHC proteins.

















I HLA-A*0201 2v2w 1qrn HLA-A*0201 9 SLYNTVATL 0.63 0.38
I HLA-A*0201 1hhh 1qrn HLA-A*0201 10 FLPSDFFPSV 0.58 0.25
I HLA-A*0201 1qse 1qrn HLA-A*0201 9 LLFGYPRYV 0.62 0.30
I HLA-A*0201 2bnq 1qrn HLA-A*0201 9 SLLMWITQV 0.97 0.77
I HLA-A*0201 2gj6 1qrn HLA-A*0201 9 LLFGKPVYV 0.56 0.24
I HLA-A*0201 1qr1 1qrn HLA-A*0201 9 IISAVVGIL 0.87 0.36
I HLA-A*0201 1qsf 1qrn HLA-A*0201 9 LLFGYPVAV 0.94 0.41
I HLA-A*0201 1bd2 1qrn HLA-A*0201 9 LLFGYPVYV 0.68 0.46
I HLA-A*0201 1hhg 1i4f HLA-A*0201 9 TLTSCNTSV 0.58 0.56
I HLA-A*0201 1hhh 1i4f HLA-A*0201 10 FLPSDFFPSV 1.48 0.57
I H2-Kb 1osz 1nam H2-Kb 8 RGYLYQGL 0.85 0.47
I H2-Kb 1fo0 1nam H2-Kb 8 INFDFNTI 0.62 0.35
I H2-Kb 1g6r 1nam H2-Kb 8 SIYRYYGL 0.66 0.11
I H2-Kb 1kbg 1nam H2-Kb 8 RGYVYXGL 0.40 0.06
I H2-Kb 1g7p 1nam H2-Kb 9 SRDHSRTPM 1.41 0.82
II HLA-DRB1*0101 1fyt 2iam HLA-DRB1*0101 13 PKYVKQNTLKLAT 0.69 0.35
II HLA-DRB1*0101 1klu 2iam HLA-DRB1*0101 15 GELIGTLNAAKVPAD 0.85 0.59
II HLA-DRB1*0101 1t5w 2iam HLA-DRB1*0101 13 AAYSDQATPLLLS 0.99 0.65
II HLA-DRB1*0101 1pyw 2iam HLA-DRB1*0101 9 FVKQNAXAL 0.40 0.32
II HLA-DRB1*0101 1sje 2iam HLA-DRB1*0101 15 PEVIPMFSALSEGAT 0.70 0.37
II HLA-DRB1*0101 1aqd 2iam HLA-DRB1*0101 14 GSDWRFLRGYHQYA 1.68 1.01
Ca RMSD values are calculated only for the nonamer binding core (shown in bold) for peptides with more than 9 residues in the X-ray crystal structures. X:
Amino acid analogues (chemical mimics).




















I HLA-B*3501 1zhk# 1zhl# HLA-B*3508 13 LPEPLPQGQLTAY 0.62 0.44
I HLA-B*3501 1zsd # 2ak4 HLA-B*3508 11 EPLPQGQLTAY 1.15 0.79
I H2-Kb 2vaa# 1ce6 H2-Db 9 FAPGNYPAL 0.73 0.21
II HLA-DRB1*1501 1bx2# 1fv1 HLA-DRB5*0101 14 ENPVVHFFKNIVTP 1.01 0.22
Ca RMSD values are calculated only for the nonamer binding core (shown in bold) for peptides with more than 9 residues in the X-ray crystal structures. # The
structures are not listed in Additional file – Table S1 due to redundancy in MPID-T2.
Khan and Ranganathan Immunome Research 2010, 6(Suppl 1):S2
http://www.immunome-research.com/content/6/S1/S2
Page 11 of 16
Conclusions
We have developed pDOCK as a fast, accurate and
robust method for flexible docking of peptides to MHC-
I and MHC-II proteins. Our results provide evidence of
overcoming limitations pertaining to the application of
our previous methodology, such as the presence of
water molecules in and around the peptide and within
the peptide binding groove in the template and relatively
longer computational time required. Benchmarking with
our previous method for a dataset of 50 non-redundant
pMHC complexes consistently produced least energy
docked conformations of peptides below 1.00 Å Ca
RMSD from their respective native orientations for all
50 peptides. The Ca RMSD range for the same dataset
was 0.09 Å (1s7q) to 0.66 Å (1i1y) using pDOCK com-
pared to a Ca RMSD range from 0.20 Å (1s7q) to 1.53
Å (1jf1) applying our previous protocol. These observa-
tions imply an improvement in the accuracy by upto
two and a half folds compared to our previous protocol.
The outcomes of our validation experiments suggest a
seven-fold improvement in the accuracy of the pDOCK
docking protocol. pDOCK can therefore be successfully
applied as a generalized, efficient protocol for docking
of peptides to MHC-I and MHC-II receptors with
improved accuracy, greater coverage of peptide residues
and vastly reduced computational time (up to 60% com-
pared to our earlier method).
The average time taken to perform each step using
pDOCK has also improved drastically compared to our
old technique on a 2 CPU 3.20 GHz 3 GB RAM work-
station. This is mainly due to the consolidation of the
docking and refinement protocols into a single step
docking and refinement procedure. Our results establish
the efficacy of pDOCK to model highly accurate pMHC
complex structures permitting conformational sampling
of the peptide in MHC binding groove. The current
study thus presents one of the most accurate pMHC
docking protocols developed to date. pDOCK targets a
more generic approach to generation of docked confor-
mations of peptides using a single template for each
allele. For some pMHC complexes however, appropriate
addition of mediating molecules or considerations of
solvent effects may lead to a possible improvement in
docking accuracy. Rapid and large scale docking and
scanning for identification of potential candidates for
immunogenicity from repertoires of immunologically
significant antigenic peptide sequences is possible by
automating all the steps. No requirement for experimen-
tal data to be trained and the need of only a suitable
template for a particular allele give pDOCK a prominent
edge over other sequence-based techniques such as Arti-
ficial Neural Networks, Support Vector Machines, and
Hidden Markov Models.
pDOCK is also highly efficient in accurately predicting
the docked conformations of amino acid analogues or
chemical components within the peptide ligand suggest-
ing its possible use as a docking and evaluation tool in
structure-based drug design protocols and chemoinfor-
matics. The single and variant template docking experi-
ments along with the validation experiments also serve
as strong benchmarks for pDOCK against our old
method. pDOCK can correctly predict the conformation
of residues that extend into the MHC binding cleft and
therefore could help identify essential contacts with the
MHC receptor, responsible for reducing the half life of
the pMHC complex such that the peptide is held long
enough within the MHC groove for presentation at the
APC cell surface leading to surveillance and recognition
by the TR molecules which in turn results in the activa-
tion of T cells and triggers the adaptive immune
response cascade. Another significant improvement in
this study is that the peptide ligand is allowed full flex-
ibility within the peptide biding groove of the MHC
proteins, unlike our previous method where the peptide
termini were docked rigidly to the MHC groove. This
aspect of pDOCK has helped us carry out fully flexible
peptide docking to the MHC proteins. Our results also
indicate the successful application of this protocol for
easy in silico identification of promiscuous peptide epi-
topes that are applicable to higher proportions of
human population with greater propensity to bind to
MHC proteins and consequently activate T cells making




pDOCK was tested on a non-redundant dataset of 186
(149 MHC-I and 37 MHC-II) pMHC complexes from
the MPID-T2 (http://biolinfo.org/mpid-t2) database for
which X-ray crystal structures are available in the PDB
and the IMGT/3Dstructure-DB. When there is more
than one complex with the same bound peptide and the
same allele, the structure with the highest resolution is
selected to avoid redundancy. When more than one
bound peptide is available in the selected crystal struc-
ture, all bound peptides in that crystal structure are ana-
lyzed. TR/pMHC structures in MPID-T2 database are
treated as non-redundant entries unless they have the
same peptide, allele and TR type. In which case, the
structure with the best resolution is considered non-
redundant. Similarly, a dataset of 25 (18 MHC-I and 7
MHC-II) pMHC complexes was selected from the
pDOCK test set for single and variant template docking.
When more than one allele is available as template for
docking of peptides into a single or variant template,
Khan and Ranganathan Immunome Research 2010, 6(Suppl 1):S2
http://www.immunome-research.com/content/6/S1/S2
Page 12 of 16
the allele with the highest resolution was selected.
Redundancy in MPID-T2 data is primarily decided from
the similarities in peptides, MHC alleles and TR types
(in case of TR/pMHC structures). Since one publication
can refer to crystal structures of many complexes,
redundancy in the literature is not considered as a cri-
terion for redundancy. Some redundant structures were
used for variant template docking (Table 5) due to lim-
ited number of crystal structures with promiscuous pep-
tides bound to different alleles in the PDB. Although the
MPID-T2 database contains 294 pMHC complexes (273
classical and 21 non classical), the 21 non-classical and
87 redundant structures were discarded from this study
in order to avoid any biasness in our results.
pMHC complexes for benchmarking and validation
A non-redundant dataset of 50 high quality (35 MHC-I
and 15 MHC-II) pMHC complexes, with maximum 3.00
Å resolutions, was selected from the 186 pMHC com-
plexes in the pDOCK test set for benchmarking with
the previous methodology. 15 pMHC complexes were
chosen for validation experiments depending on the
ones used in the corresponding reference studies
[34,36-42].
The pDOCK protocol
Unlike our earlier method [2,3], the new technique
incorporates flexibility into the entire length of the pep-
tide ligand. We have now incorporated a receptor mod-
eling sub-step at the beginning of our novel schema
(Figure 1), which involves rigorous homology modeling
of MHC proteins from available MHC sequences by
satisfaction of spatial restraints using MODELLER [43]
followed by structure optimization and stringent struc-
tural quality assessment protocols to affirm the genera-
tion of high quality homology models of MHC proteins
to be subsequently used in the pMHC docking strategy.
Thereby, accounting for the validity of our methodology
even in the absence of experimental structures for the
MHC proteins and when only MHC sequences are
available. However, this sub-step was not used in the
current study as testing, benchmarking, validation, single
template and variant template docking experiments are
performed only on X-ray crystal structures of pMHC
complexes.
The current pMHC docking technique is applied on
MHC-I and MHC-II related peptides in two preparatory
steps and a single consolidated docking and receptor
step as follows: Preparatory step 1: receptor positioning
using the Internal Coordinate Mechanics (ICM) global
optimization algorithm [35]; Preparatory step 2: deter-
mining the docking grid using standardized values for
MHC supertypes (MHC-I and MHC-II) from our preli-
minary studies and; A single docking and refinement
step involving: ligand positioning, grid ligand docking
followed by iterative ab initio refinements of backbone
and ligand interacting side-chain dihedral angles of the
MHC binding site residues to eliminate or minimize
atomic clash regions at the pMHC interface using a
Biased Monte Carlo procedure. The preparatory steps
were together used to generate the receptor maps and
the final single docking and refinement step was used to
carry out ligand docking, generate the final least energy
conformation and further refine the product.
Preparatory steps
Receptor modeling and positioning
Positioning of the MHC receptor is a major requirement
in the pMHC docking simulation to ensure a best fit of
the flexible peptide in the MHC groove. This first pre-
paratory step (receptor modeling and positioning) is the
least time consuming (only applicable to sub-step ‘b’) in
the pDOCK docking protocol and involves two vital
sub-steps: (a) homology model building by satisfaction
of spatial restraints for MHC sequences where no struc-
tural data is available or inserting the MHC crystal
structure into the docking simulation and; (b) position-
ing of the receptor within the docking simulation.
Although not used in this study, high quality homology
models can be generated, using our previously described
three-step homology modeling procedure [44], for alleles
with no structural data. Receptor positioning using the
ICM global optimization algorithm assures the addition
of any important missing residues in the template
besides optimizing the zero occupancy side chains and
any polar hydrogen atoms.
Determining the docking grid
The second, relatively small preparatory step of our
docking procedure is to determining the docking grid
which constitutes two major sub-steps: (a) defining the
dimensions (length x breadth x height) of the 3-D dock-
ing grid and; (b) grid map generation for the receptor
using the ICM stochastic global optimization algorithm.
The ICM algorithm generates a three-dimensional dock-
ing grid (purple box in Figure 6), which encloses all
MHC binding site residue atoms along with peptides
residue atoms, soon after the previous step for genera-
tion of receptor maps. This ensures the localization of
the peptide ligand for docking within the vicinity of the
MHC peptide binding site residues and thereby limits
the flexibility of the allowed peptide side chain torsion
angles to be randomly sampled within the MHC groove.
The dimensions of this 3-D docking box are set to stan-
dardized values derived from our preliminary analysis of
all available pMHC complexes from the MPID-T2 data-
base, for both MHC-I (35.36 Å x 35.52 Å x 35.79 Å)
and MHC-II (58.32 Å x 56.36 Å x 48.87 Å) complexes
used in testing, benchmarking, validation, single and
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variant template docking simulations. The ICM algo-
rithm then selects all the binding site residues within
the MHC groove by creating three-dimensional spheres
from and around the centre of the MHC groove with
5.00 Å radii and selecting all the atoms of the MHC
binding groove residues falling in and on the spheres
(shown in green in Figure 6). 5.00 Å is set as the default
radii to select the binding site residues amongst the resi-
dues forming the MHC groove as these are the MHC
residues that are most likely to form hydrogen bonds
(maximum allowed distance – 3.65 Å) and van der
Waals contacts (maximum allowed distance – 4.50 Å)
with the peptide residues, resulting in strong enough
interactions to hold the bound peptide for presentation
at the APC cell surface leading to surveillance and
recognition by the TR molecules. The stochastic global
optimization in internal coordinates with pseudo-Brow-
nian and collective “probability-biased” random moves
allow flexibility to the peptide ligand interface side
chains and generate a grid potential map of the receptor
energy localized to small cubic regions of side 1.00 Å
from the carbon-alpha backbone of the peptide.
Single step docking and refinement
Ligand positioning, grid ligand docking and refinement
As with receptor positioning, ligand positioning is also
equally important in achieving the best docked confor-
mations, with the lowest energy values for flexible pep-
tides using pDOCK. The final, most exhaustive (in
terms of computational time required compared to the
other two steps) single step docking and refinement part
deals with ligand positioning, grid ligand docking and
refinement, comprising three very important sub-steps:
(a) positioning of the peptide ligand either by using the
original crystal structure or by inserting a peptide model
into the docking simulation using the peptide sequence;
(b) placing and positioning of the probe into the peptide
binding groove using the Internal Coordinate Mechanics
global optimization algorithm and; (c) flexible docking
of the peptide into the MHC groove and refinement of
all ligand and binding site residues using a Biased
Monte Carlo procedure. Ligand positioning was carried
out either by using ICM algorithm for existing peptides
within the X-ray crystal structures of pMHC complexes
or by manually inserting a peptide model into the dock-
ing simulation for each of the available peptide
sequences (docking of novel peptides to a single tem-
plate and docking of promiscuous peptides to variant
templates). This was followed by placing a probe (red in
Figure 6) in the MHC groove which provides an initial
position for conformational sampling and docking simu-
lations using the ICM algorithm.
ICM docking algorithm [35] runs flexible docking of
peptide ligands to MHC peptide binding clefts. During
the docking simulation, the ligand side-chain torsions
that have been previously stored within the grid recep-
tor maps (preparatory step 2) are changed in each ran-
dom step using a Biased Monte Carlo procedure, which
begins by pseudo-randomly selecting a set of torsion
angles in the ligand and consequently finding the local
energy minima about those angles. Upon satisfaction of
the Metropolis criteria, novel conformations are adopted
with a probability min (1, exp[−ΔG/RT]), where R is the
universal gas constant and T is the absolute temperature
of the simulation. The temperature was set to 300 K for
the current study. To keep the ligand molecule close to
the starting conformation, loose restraints are imposed
on its positional variables. The internal energy function
adopted for our simulations integrates internal van der
Waals interactions energy (calculated using an extension
of ECEPP/3 with force field parameters) [45], hydrogen
bonding energy, torsion energy, electrostatic energy with
a distance-dependent dielectric constant (ε = 4r; where ε
is the distance-dependent dielectric constant and r is the
distance) [46] and hydrophobic potential between the
atoms of peptide residues and atoms of the binding site
residues. The final energy incorporates configurational
entropy of side chains and the surface-based solvation
energy to select the best-iterated orientations. In brief,
the complete optimal energy function, E, is made up of
the internal energy of the ligand and the intermolecular
energy of the optimized receptor potential maps and
can be summarized as:
E = Evw + Een + 2.16 E el
Solv + 2.53 Ehb + 4.35 Ehp
+ 0.20 Esolv
Figure 6 pMHC docking caught in action. Docking of the
peptide into the MHC peptide binding ‘groove’ is shown for the
pMHC complex 1zhb. The various components like binding site
residues (green), docking grid (purple) dimensions (length, breadth
and height), probe (red) and peptide (blue), involved in the peptide
docking protocol are labeled.
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where Evw is the internal van der Waals interaction
energy, Een is the configurational/conformational entropy,
E el
Solv is the electrostatic energy of solvation, Ehb is the
hydrogen bonding energy, Ehp is the hydrophobic potential
and Esolv is the surface-based solvation energy.
Finally, to improve the accuracy of the initial predicted
conformation, refinement of the ligand as well as bind-
ing site residues backbone and side chains was per-
formed as described in our previous methodology [2,3]
to overcome any atomic clashes detected at the pMHC
binding interface, using ICM Biased Monte Carlo proce-
dure. Again, restraints are imposed upon the positional
variables of the Ca atoms of the peptide residues. The
early stages of the refinement efforts try to trounce the
consequences of docking fully flexible ligands to rigid
receptors by introducing partial flexibility to the back-
bone of MHC peptide binding residues. Refinements of
ligand and receptor side-chain torsions in the vicinity of
4.00 Å from the receptor were executed upon the final
backbone structure of the peptides to keep the docked
peptides closest to their starting conformations. The
energy function, E, utilized for this refinement sub-step,
is the sum of energy terms arising from the optimal
energy function described above:
E = Evw + Ehbonds + Etors + Eelec + Esolv + Een
where Etors is the torsion energy, Eelec is the electro-
static energy and Een is the entropic term.
Additional File 1: Table S1. Application of pDOCK to the 186 (149
MHC-I and 37 MHC-II) non-redundant structures from MPID-T2
database. (*.pdf)Application of pDOCK to the 186 (149 MHC-I and 37
MHC-II) non-redundant structures from MPID-T2 database.
Additional File 2: Figure S1. Comparison of Ca RMSD values
obtained using pDOCK and our previous method across the
benchmarking dataset (*.pdf)Comparison of Ca RMSD values obtained
using pDOCK and our previous method across the benchmarking dataset
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